Advisor Partners’s AngioDynamics ANGO Stock Holding History

Advisor Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,823	Closed	-$133K	–	688
2020 Q1	$133K	Buy	+12,823	New	+$161K	0.02%	572

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Advisor Partners's ANGO Position: Q2 2020 in Review

Advisor Partners sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 12,823 shares — an estimated $133K sold.

Advisor Partners first reported a position in ANGO in Q1 2020 and held it in 1 quarter. The position peaked at $133K in Q1 2020. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Advisor Partners reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
Advisor Partners sold 12,823 AngioDynamics shares in Q2 2020, an estimated $133K.
Advisor Partners first reported a position in AngioDynamics in Q1 2020 and held it in 1 quarter.
Advisor Partners's AngioDynamics position peaked at $133K in Q1 2020.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Advisor Partners's 13F filing for Q2 2020, filed 12 Aug 2020.